Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL544P is a human pseudogene belonging to the 7SL RNA gene family. The canonical gene (7SL RNA) is a key component of the signal recognition particle (SRP), which directs nascent polypeptides to the endoplasmic reticulum for membrane translocation. However, RN7SL544P is a truncated, nonfunctional copy that does not encode a functional RNA or protein and is classified as a processed pseudogene. It is listed as an inactive locus in the human genome and lacks demonstrated biological or clinical relevance[1][6][3][5].
None (No active mechanism for a pseudogene. Functional 7SL RNA is involved in ribonucleoprotein assembly and translation regulation, but the pseudogene is nonfunctional)[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 544, pseudogene (RN7SL544P).